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Abstract
Purpose: To investigate the feasibility of a novel dedicated treatment planning solution, to automatically target
multiple brain metastases with a single isocenter and multiple inversely-optimized dynamic conformal arcs (DCA),
and to benchmark it against the well-established multiple isocenter DCA (MIDCA) and volumetric modulated arc
therapy (VMAT) approaches.
Material and Methods: Ten previously treated patients were randomly selected, each representing a variable
number of lesions ranging between 1 to 8. The original MIDCA treatments were replanned with both VMAT and
the novel brain metastases tool. The plans were compared by means of Paddick conformity (CI) and gradient index
(GI), and the volumes receiving 10 Gy (V10) and 12 Gy (V12).
Results: The brain metastases software tool generated plans with similar CI (0.65 ± 0.08) as both established
treatment techniques while improving the gradient (mean GI = 3.9 ± 1.4). The normal tissue exposure in terms of
V10 (48.5 ± 35.9 cc) and V12 (36.3 ± 27.1 cc) compared similarly to the MIDCA technique and surpassed VMAT plans.
Conclusions: The automated brain metastases planning algorithm software is an optimization of DCA radiosurgery
by increasing delivery efficiency to the level of VMAT approaches. Improving dose gradients and normal tissue
sparing over VMAT, revives DCA as the paradigm for linac-based stereotactic radiosurgery of multiple brain
metastases.
Keywords: Stereotactic radiosurgery, Brain metastases, Automated planning optimization, Single isocenter dynamic
conformal arc
Introduction
Radiation therapy has become a popular treatment
option in the management of patients with brain metas-
tases. The role and effectiveness of stereotactic radiosur-
gery (SRS) alone and in combination with whole brain
radiation therapy (WBRT) for the treatment of brain
metastases has been evaluated in two randomized clin-
ical trials [1, 2]. One decade later, debate continues on
to the role of SRS as the first line of care treatment mo-
dality for brain metastases patients, yet the controversy
has shifted from overall survival to quality of life and
how this relates to neurocognitive decline, which is a
more appropriate endpoint in times of personalized
medicine. In the absence of level-1 evidence, best prac-
tice guidelines recommend a close monitoring of pa-
tients treated solely with SRS for an early detection of
distant recurrences. The guidelines of the American
Society of Radiation Oncology only support SRS without
concurrent WBRT for patients with up to four brain me-
tastases [3]. The reported successful radiosurgical out-
come for two patients with ten or more metastases
suggested at the absence of an essential number of me-
tastases that can be treated with radiosurgery [4, 5]. Re-
cently, Yamamoto et al. performed a multi-institutional
prospective observational trial (JLGK0901) and concluded
that SRS without WBRT as the initial treatment for
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patients with five to ten brain metastases is non-inferior
to SRS alone in those with two to four brain metastases,
in terms of overall survival [6]. Although a randomized
trial should confirm these results, evidence grows that
SRS alone is an important treatment option for brain me-
tastases patients, irrespective of the number of metastases.
Different radiosurgery technologies are available and
accomplish the high ablative dose with a sharp dose
fall-off in their respective ways. The dose distribution
generated with a gantry-mounted linear accelerator
(LINAC)-based SRS system is accomplished using
multiple intersecting non-coplanar dynamic conformal
arcs (DCA), multiple intensity-modulated beams or
volumetric modulated arc therapy (VMAT). A previ-
ous study in our department showed that for linac-
based SRS, DCA is still favorable to sculpt the dose
around the lesion with respect to SRS treatment aims
(i.e., high conformity and sharp gradient) [7]. Therefore,
our standard of care for SRS treatments of multiple brain
metastases is a multi isocentric set-up, aligning the micro
multi-leaf collimator (MLC) around every individual le-
sion using DCA. This complex time consuming treatment
planning translates in extended treatment delivery times,
as it requires patient repositioning for every individual
metastases.
Recently, a new dedicated brain metastases treatment
planning solution has been developed, intended to care-
fully balance normal tissue protection, target coverage
and treatment efficiency. The automated brain metasta-
ses treatment planning software, named Elements, gen-
erates radiosurgery-grade treatment plans to treat up to
ten metastases simultaneously with a single isocenter.
The purpose of the current study was to investigate
the feasibility of this novel treatment planning software
for single isocenter SRS treatment in patients with mul-
tiple brain metastases and to compare the dosimetry and
efficiency against the well-established multiple isocenter
dynamic conformal arc (MIDCA) approach and the sin-
gle isocenter VMAT approach.
Material and methods
Patient population
Ten patients were randomly selected from the pool of
previously treated brain metastases patients with the
Novalis at the UZ Brussel hospital. They represent a
variable number of lesions, range of target sizes and
shapes most frequently observed in the practice of SRS
for brain metastases. The number of lesions varied from
1 (n = 1), 2 (n = 2), 3 (n = 3), 4 (n = 1), 7 (n = 2) to 8 (n = 1).
The gross target volume (GTV) was defined as the area of
contrast enhancement on MRI and was expanded with
2 mm based on our experienced and previous published
data on intrafraction motion [8]. After delineation of tar-
gets and critical structures on MRI data sets, the CT data
with their related DICOM Radiotherapy Structure Sets
were transferred to several dedicated treatment planning
systems: iPlan dose v.4.5 (Brainlab AG, Feldkirchen,
Germany) for MIDCA treatment planning, Eclipse
RapidArc v10 (Varian, Palo Alto, CA, USA) for
VMAT treatment planning, and to the automated
brain metastases treatment planning software (Brainlab
Elements, Brainlab AG, Feldkirchen, Germany) for single
isocenter dynamic conformal arc (SIDCA) treatment plan-
ning. The treatment dose of 20 Gy was prescribed to the
80 % isodose line covering 99.5 % of the target volume.
The dose to the surrounding healthy brain and critical
structures (brainstem, cochlea, optical nerve, eyes and
lens) were optimized to minimize complications for all the
plans generated. A Novalis Tx (Brainlab AG, Feldkirchen,
Germany) radiosurgery linac with 6 MV photon energy
equipped with an integrated high definition multi-leaf col-
limator (Varian, Palo Alto, CA, USA), consisting of 120
leaves, including 64 central leaves with a width of 2.5 mm
and 56 peripheral leaves with a width of 5 mm [9], was
modelled for all treatment planning purposes.
Dedicated automated brain metastases treatment
planning
This novel automated software solution is designed to
simulate treatments for multiple individual metastases
simultaneously. The contours are automatically imported
for a correct comparison. The isocenter position is deter-
mined as the average position of the centers of mass of
each individual target. The dose prescription is defined as
the dose applied to 99.5 % of the target volume and this
coverage is guaranteed by the optimization algorithm. The
software uses a pre-configured set of non-coplanar DCA
to treat the targets. The algorithm starts by considering a
maximum of five couch positions and two independent
arcs per couch position. By default, the couch positions
are defined so that the arcs are equally distributed and op-
posing arcs are avoided. Depending on which hemisphere
of the head the isocenter is located in, the arcs are mir-
rored about the sagittal plane. The start and stop angles of
the arc are first set to default values and automatically
modified during optimization. The MLC leaf positions are
shaped conform to the targets, with an additional margin
of up to 1 mm in addition to any margin that may have
been defined in the template, for all fields of each arc. To
prevent irradiation of normal tissue, all targets must be
assigned to specific arcs and not necessarily treated by all
arcs at the same time. In the latter scenario, it might occur
that multiple targets line up along the direction of motion
of a leaf pair, which would imply the pair to open widely
and also expose the healthy tissue in between the targets.
Therefore, each leaf pair is only allowed to expose one tar-
get at any time. This decision of assigning lesions to a spe-
cific arc is automatically performed by the algorithm itself.
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For the sake of efficiency, the algorithm bases this choice
on the principle that as many targets as possible should be
treated by each arc. The choices are made so that minimal
number of arcs is used based on the amount of parallel le-
sions that can be treated by one arc. Additionally, a large
range of collimator rotations is explored to smear out the
overdosage caused by the radiation leakage between MLC
leaves. Although this rotation is limited because all targets
treated by an arc still have to fit into the effective MLC
field, its contribution to the protection of healthy tissue is
still deemed to be significant. After assigning individual
targets to arcs, the weights of the arcs are optimized in
terms of conformity and expressed by the conformity
index (CI), one for each target. In addition to optimizing
the arc weights, the algorithm evaluates several other ap-
proaches to improve the conformity further, like adding or
subtracting small margins around the targets with sub-
optimal CI and varying start and stop angles of each arc.
Figure 1a shows an example of the number of arcs, ar-
rangement used for the treatment of a patient with 7 brain
metastases.
Established radiosurgery treatment strategies
The DCA modality [10], which is used routinely at our
department for the SRS treatments, is a rotational arc
delivery technique in which the leaves move during the
rotation of the gantry to dynamically adapt the shape of
the treatment beam to the projection of the target. In
this study, one isocenter for each target with 4–5 arcs
equally distributed over 100–150° was used to treat the
target. The couch angles of the arcs were manually se-
lected to minimize dose spread in normal brain as well
as avoiding multiple targets to line up along the
direction of an arc. Forward planning is applied to shape
the prescription isodose (80 %) conform to the lesions.
The isocenter of each group was at the center of mass of
the associated target.
The VMAT plans were developed according to the
technique described by Clark et al. [11]. Constraints to
targets and OAR were applied in order to achieve the
planning objectives. Concentric ring-structures were uti-
lized during optimization to achieve the steepest dose
fall-off possible. Huang et al. [12] suggested VMAT
plans with 4 arcs in order to achieve the steepest dose
fall-off. The 4-arc plans consisted of one 358° axial arc
and three 171° arcs at couch angles of 45°, 90°, and 315°.
During optimization, priorities were adjusted during
optimization to achieve the best results for each patient.
VMAT Rapidarc (Varian, Palo Alto, CA, USA) consists
of optimizing a dose distribution from dose–volume ob-
jectives. The optimizer is enabled to continuously vary
the dose rate, MLC leaf positions and gantry rotation
speed. The optimization itself is based on the “Progressive
Resolution Optimization” algorithm. This optimization
loop is based on a multi-resolution level and is ruled by
means of a gradient back projection algorithm to
minimize differences between current and desired doses
in the cost function built on dose volume objectives de-
fined by the planner. Variations of MLC shapes, dose rate
or gantry speed settings are performed in the search of the
optimal solution. An intrinsic stochastic component will
avoid traps in local minima during this search.
Figure 1b and c, respectively for MIDCA and VMAT,
shows the arc arrangement, length and number used
in order to optimize a plan for a patient with 7 brain
metastases.
Plan comparison
In the radiosurgery community, the Paddick CI and gra-
dient index (GI) are two well-known indices to analyze
Fig. 1 Arc arrangement for the three different treatment modalities:
(a) Single isocenter dynamic conformal arc (SIDCA), (b) Multi
isocenter dynamic conformal arc (MIDCA) and (c) Volumetric
Modulated Arc technique (VMAT)
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how conformal the prescription dose sculpts the target
volume and how steep the dose fall-off is in the brain.
The Paddick CI, providing simultaneously information
about the irradiation of the target volume and healthy
tissues, was used for analysis [13]. To reflect the dose
fall-off outside the target, the Paddick GI was used [14].
Blonigen et al. [15] found a higher risk for symptom-
atic radionecrosis for plans showing a large isodose vol-
ume receiving a dose of 12 Gy and 10 Gy. The positive
correlation between the volume of the low dose outside
the target and radiosurgical complications confirms the
importance of the intermediate doses (10 and 12 Gy) for
the prediction of complications. That is why we also
evaluated the volume of brain receiving a dose of 10 Gy
(V10) and 12 Gy (V12), respectively. The volume receiv-
ing a low isodose (5 Gy) was also analyzed.
Statistical analysis
A student t-test (Microsoft Office Excel; Microsoft
Corporation, Redmond, WA, USA) was performed to
obtain p-values to evaluate the differences between the
different indices of the systems.
Results
Ten patients with in total 40 lesions were planned with
the novel SIDCA treatment planning element, MIDCA
and VMAT. The mean lesion size was 3.15 cc (range
0.14–24.61 cc). The mean total treated volume per pa-
tient was 10.60 cc (range 0.60–28.66 cc). All plans were
judged clinically acceptable regarding target coverage
and organs at risk sparing, although differences in dosi-
metrical parameters were observed. Table 1 summarizes
the different indices. Figure 2 gives an example of dose
distribution achieved for a patient with 7 brain metasta-
ses with the three different planning systems.
The mean conformity of the automated single-isocenter
planning tool (SIDCA plans) compared similarly to the
established MIDCA and VMAT treatment techniques
(CISIDCA = 0.65 ± 0.08, CIMIDCA = 0.66 ± 0.07 and CIVMAT =
0.67 ± 0.16). Comparable mean dose fall off was observed
between SIDCA and MIDCA (GISIDCA =3.9 ± 1.4 and
GIMIDCA = 4.5 ± 1.6). On the other hand, compared to
another single isocenter treatment, the GI and low dose of
the VMAT plans (GIVMAT = 7.1 ± 3.1) were significantly
higher compared to the automated single isocenter plan-
ning tool (SIDCA). The V10 and V12 were significantly
higher for VMAT plans (V10VMAT = 67.9 ± 55.9 cc,
V12VMAT = 46.3 ± 35.9 cc) (p < 0.05) compared to MIDCA
(V10MIDCA = 49.0 ± 38.1 cc, V12MIDCA = 35.6 ± 26.4 cc) and
SIDCA (V10 = 48.5 ± 35.9 cc, V12 = 36.3 ± 27.1 cc).
Low dose spread, expressed as the volume receiving
5 Gy (V5), was significantly higher for VMAT plans
(V5VMAT = 266.7 ± 216.7 cc) compared to the MIDCA
(V5MIDCA = 173.7 ± 138.0 cc) and SIDCA (V5 = 161.6 ±
143.6 cc).
If we stratify the total patient population into two
groups, one comprising patients with up to 3 lesions and
one comprising patients with more than 3 lesions, we
found comparable conformity across both groups re-
gardless of the delivery technique. For the gradient and
low dose spread, the differences between the SIDCA and
MIDCA versus VMAT were even more pronounced for
patients with more than three lesions (Table 1).
Discussion
Increasing evidence demonstrates that SRS provides
highly effective and predictable local tumor control for
single and multiple brain metastases. Avoidance of
WBRT can have a positive impact on the patient’s cogni-
tive status and health-related quality of life. Nowadays,
there is clinical evidence to treat multiple brain metasta-
ses up to 10 upfront with a single radiosurgery session
and apply repeat SRS when new lesions are detected
[1–6]. Different dedicated radiosurgery systems (i.e.,
Gamma Knife, Cyberknife and linac-based systems)
are available to perform these very precise single
Table 1 Different dosimetrical paramters (i.e., conformity index (CI), gradient index (GI) and volume receiving 12Gy (V12), 10Gy (V10)
and 5Gy (V5) for the different treatment techniques: multiple isocenter dynamic conformal arc (MIDCA), single isocenter DCA and
volumetric modulated arc therapy (VMAT)
CI GI V12 (cc) V10 (cc) V5 (cc)
1–3 lesions (n = 14) MIDCA 0.67 ± 0.06 3.9 ± 1.5 30.4 ± 24.6 39.5 ± 31.0 131.1 ± 107.6
SIDCA 0.67 ± 0.07 3.3 ± 0.6 31.9 ± 24.9 41.6 ± 31.0 118.9 ± 85.1
VMAT 0.69 ± 0.20 5.3 ± 2.2 38.1 ± 28.9 52.9 ± 39.9 191.1 ± 174.1
>3 lesions (n = 26) MIDCA 0.66 ± 0.08 4.9 ± 1.5 45.8 ± 32.2 68.2 ± 50.8 258.9 ± 175.8
SIDCA 0.63 ± 0.08 4.5 ± 1.7 45.0 ± 34.8 62.3 ± 48.3 247.0 ± 219.0
VMAT 0.65 ± 0.14 8.5 ± 3.0 62.9 ± 49.6 98.0 ± 80.6 418.0 ± 246.3
All lesions (n = 40) MIDCA 0.66 ± 0.07 4.5 ± 1.6 35.6 ± 26,4 49.0 ± 38.1 173.7 ± 138.0
SIDCA 0.65 ± 0.08 3.9 ± 1.4 36.3 ± 27.1 48.5 ± 35.9 161.6 ± 143.6
VMAT 0.67 ± 0.16 7.1 ± 3.1 46.3 ± 35.9 67.9 ± 55.9 266.7 ± 216.7
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fraction SRS treatments. We previously compared
these different devices for vestibular schwannomas
and arteriovenous malformations and found that al-
though all systems achieve SRS requirements, mul-
tiple focal entries (i.e., Gamma Knife and Cyberknife)
achieve better conformity while modulated beams
(Cyberknife and IMRT beams) will spread more low
dose into the brain [7]. The DCA technique, which is
routinely applied in our department, achieved good
conformity with a reduction in low dose spread com-
pared to the modulated beams. These results also
apply to single brain metastases radiosurgery. How-
ever, for multiple brain metastases, careful selection
of arc orientation is needed in order to avoid possible
overlap of arcs, which will result in decreased con-
formity, and higher volume of low doses into the
brain leading to undesirable side effects. Valéry et al.
[16] determined that the risk of radionecrosis after
radiosurgery is related to the presence of normal tis-
sue included in the prescription volume and found
that the conformity of a treatment plan was the only
parameter influencing the risk of radionecrosis. Fur-
thermore, dose fall-off outside the target is of equal
importance as conformity. Analysis of risk factors for
brain necrosis showed that V10 and V12 were the
most important independent predictors of both symp-
tomatic and asymptomatic radionecrosis indicating
that volume is more important than the number of
lesions treated [17]. Furthermore, Xue et al. [18]
found that mean normal brain dose correlated with
the total volume of the lesions rather than with the
treated number of lesions.
Multiple isocenter DCA radiosurgery is less efficient
in treating multiple lesions as treatment planning in-
volves different isocenters, each with an arc arrange-
ment. In order to reduce low dose spread, arc length
and direction must be optimized. Patients also need to
be repositioned for every lesion separately, which is
more time consuming.
Single isocenter treatments are more efficient for
multiple brain metastases. Mayo et al. [19] showed
the possibility to use VMAT to treat multiple meta-
static lesions using a single isocenter with multiple
arcs and anticipated that the ability to treat multiple
lesions simultaneously will have a significant impact
on care patterns for this patient population. Although
this technique looks interesting, Huang et al. [20]
found an increased low-dose spread that may be of
concern. This technique is designed for speed, as
there is no difference in treatment time whether you
treat one or multiple metastases. However, this ap-
proach comes at the cost of more radiation exposure
to normal tissue, which goes against the core princi-
ples of SRS. Furthermore, based on the dose interplay
Fig. 2 Dose distribution for a patient with 7 brain metastases for the different treatment modalities: (a) Single isocenter dynamic conformal arc
(SIDCA), (b) Multi isocenter dynamic conformal arc (MIDCA) and (c) Volumetric Modulated Arc technique (VMAT)
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effect analysis, Ma et al. [21] observed that multiple
isocenter delivery (i.e., Gamma Knife and DCA)
achieves better normal brain tissue sparing as com-
pared to single isocentric or non-isocentric (i.e.,
CyberKnife) approaches. These conclusions are in ac-
cording with our previous publication where modu-
lated beams were found to smear the dose out over
the normal tissue.
In this manuscript we propose an automated algo-
rithm to treat single or multiple brain metastases
using a single isocenter with a pre-configured set of
non-coplanar DCA. All established techniques men-
tioned above rely on user-defined empirical values for
gantry angles, collimator and couch rotations, virtual
objects and their corresponding constraints. The large
number of parameters and many degrees of freedom
involved with traditional radiosurgery plan optimization
challenges the task at hand and may result in a sub-
optimal treatment plan and variable plan quality de-
pending on the experience of the user. Despite all
the parametric freedom routinely available, the plan-
ner is faced with the often conflicting ambitions of
shaping the radiation dose as conformal as possible,
while simultaneously optimizing the dose gradient.
In this scenario, as an analogy, the jockey becomes
more important than the horse. That is why it would
be beneficial to have a treatment planning system
automatically balancing the large number of parame-
ters and degrees of freedom available and presenting
a solution with minimal user interaction. The plan-
ning efforts for a forward planning technique such
as MIDCA, scale with the number of lesions. That is
why VMAT radiosurgery was likely to replace MIDCA for
multiple lesions in terms of efficiency, at the cost of in-
creased low dose spread.
The automated Elements software is also an inverse
planning optimization technique that uses a single iso-
center and several non-coplanar DCA, which makes for
an interesting tool in terms of planning and treatment
efficiency. This novel software tool generated plans with
similar conformity compared to the MIDCA and
VMAT. For the low dose spread, comparable results
were found as for MIDCA but with a significant de-
crease of low dose spread compared to the VMAT plans,
improving stereotactic treatment planning in terms of
gradient index and low dose spread while maintaining
conformity.
An important remark is that when multiple targets are
separated far from each other, some of the lesions may
be covered by the 5 mm MLC instead of the 2.5 mm.
That is why for these lesions, if conformity seems not
acceptable, a second group for that particular lesion
must be created in order to achieve the planning
constraints.
Furhter investigations must now be performed in
order to ensure that planning reproducibility can be per-
formed once the patient will be treated. A small angular
setup uncertainty can lead to significant dosimetric deg-
radation especially for lesions located distant from the
treatment isocenter. That is why stereoscopic x-ray im-
ages and 6° of freedom positioning will be used in order
to cope with those uncertainties. Previously work in our
department has showed that a threshold of 1 mm and
0.5° is sufficient to assure good dose deposition [8]. In
order to maintain the setup accuracy during table rota-
tions, we suggest to perform snapshot verifications and
reposition if necessary at that particular table angle [22].
Conclusions
The automated brain metastases treatment planning
element, based on an inversely-optimized SIDCA ap-
proach, revealed comparable results to the general
accepted and clinical used MIDCA approach. By re-
ducing the time on planning, patient setup and re-
positioning of the treatment couch, this software tool
significantly improves the treatment planning and de-
livery efficiency while preserving the plan quality of
the MIDCA technique and lowering the low dose
spread of the single isocenter VMAT approach, sug-
gesting that this novel software offers the best of both
worlds (i.e., efficient single-isocenter DCA delivery).
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